Oss, Netherlands

Niels Honcoop

This inventor holds 1 USPTO granted patent. Top assignee: Intervet Inc.. Active years: 2016.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Niels Honcoop: Innovator in Drug Delivery Systems

Introduction

Niels Honcoop is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of drug delivery systems, particularly through his innovative patent. His work focuses on enhancing the efficacy and reliability of drug release mechanisms.

Latest Patents

Niels Honcoop holds a patent for a Macrocyclic lactone drug delivery system. This invention discloses a system from which a macrocyclic lactone can be released with a desirable zero-order release profile. The system utilizes thermoplastic polymers, specifically polyethylene vinyl acetate copolymers (EVA). It comprises a solid non-porous reservoir containing the macrocyclic lactone at a concentration well above the saturation concentration, along with a non-porous skin covering the reservoir that is not initially loaded with the drug. The design is preferably in the form of a rod, with concentric core and skin, and the end surfaces of the rod are not skin-covered.

Career Highlights

Niels Honcoop is associated with Intervet Inc., where he applies his expertise in drug delivery systems. His innovative approach has positioned him as a key figure in the development of advanced pharmaceutical technologies.

Collaborations

He has collaborated with notable colleagues, including Wouter De Graaff and Raymond Zeeman, contributing to the advancement of their shared goals in the field of drug delivery.

Conclusion

Niels Honcoop's work in drug delivery systems exemplifies innovation in pharmaceutical technology. His patent for a Macrocyclic lactone drug delivery system showcases his commitment to improving drug release mechanisms. His contributions continue to influence the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…